Medical specialists from Italy tagged as investigators in clinical trials studying Eosinophilic Granulomatosis With Polyangiitis
Total 13 results
-
Angelo VaccaSeen in:
- Bari, A.O.U.C Policlinico di Bari
- Puglia, Bari, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT05879757 (Principal Investigator)
-
Augusto VaglioSeen in:
- Parma, University of Parma
Trials:- NCT01066208 (Principal Investigator)
-
Carlo SalvaraniSeen in:
- Reggio Emilia, Arcispedale Santa Maria Nuova
- Reggio Emilia, Santa Maria Nuova Hospital, Reggio Emilia
Trials:- NCT01066208 (Principal Investigator)
-
Chiara BaldiniSeen in:
- Toscana, Pisa, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Dario RoccatelloSeen in:
- Torino, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Francesco CinettoSeen in:
- Treviso, University of Padova
- Veneto, Treviso, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT05879757 (Principal Investigator)
-
Giacomo EmmiSeen in:
- Florence, A.O.U. Careggi
- Toscana, Firenze, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT05925790 (Principal Investigator)
-
Gianluca MoronciniSeen in:
- Marche, Torrette, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT05878717 (Principal Investigator)
-
Jan SchroederSeen in:
- Lombardia, Milano, GSK Investigational Site
Trials:- NCT04718389 (Principal Investigator)
- NCT05263934 (Principal Investigator)
Conditions: -
Lorenzo DagnaSeen in:
- Lombardia, Milan, GSK Investigational Site
- Lombardia, Milano, GSK Investigational Site
- Milano, GSK Investigational Site
- Milano, Ospedale San Raffaele
Trials:- NCT04718389 (Principal Investigator)
- NCT05263934 (Principal Investigator)
- NCT05531565 (Principal Investigator)
- NCT06411249 (Principal Investigator)
-
Marco TagliettiSeen in:
- Lombardia, Brescia, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Roberto GiacomelliSeen in:
- Lazio, Roma, GSK Investigational Site
- Roma, Università Campus Bio-Medico di Roma
Trials:- NCT05263934 (Principal Investigator)
- NCT04961567 (Principal Investigator)
-
Sara MontiSeen in:
- Lombardia, Pavia, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions:
Clinical Trials on Eosinophilic Granulomatosis With Polyangiitis
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupCompletedEosinophilic Granulomatosis With Polyangiitis (EGPA)France
-
Medical University InnsbruckRecruitingEosinophilic Asthma | Eosinophilic Pneumonia | EGPA - Eosinophilic Granulomatosis With Polyangiitis | Samter Triad | HES - Hypereosinophilic SyndromeAustria
-
Imperial College LondonAstraZenecaEnrolling by invitationEGPA - Eosinophilic Granulomatosis With PolyangiitisUnited Kingdom
-
University of PennsylvaniaUniversity of South Florida; University of OxfordCompletedVasculitis | Churg-Strauss Syndrome (CSS) | Microscopic Polyangiitis (MPA) | Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA) | Wegener Granulomatosis (WG) | ANCA-Associated Vasculitis (AAV)United States
-
University Medical Center GroningenGlaxoSmithKlineRecruitingEGPA - Eosinophilic Granulomatosis With PolyangiitisNetherlands
-
Portsmouth Hospitals NHS TrustCompletedChurg-Strauss SyndromeUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupActive, not recruitingEosinophilic Granulomatosis With PolyangiitisFrance
-
National Jewish HealthTeva Pharmaceuticals USAUnknown
-
GlaxoSmithKlineNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss SyndromeUnited States, France, Japan, Spain, Italy, Germany, Canada, Belgium, United Kingdom
-
GlaxoSmithKlineActive, not recruiting